Presentation TCT 2025 TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates Presenter: Hannah Kempton October 27, 2025
Presentation TCT 2025 TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients Presenter: Noah Tregobov October 27, 2025
Presentation TCT 2025 TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method Presenter: Dejing Feng October 25, 2025
Presentation TCT 2025 TCT 1: One-Year Outcomes of the RESILIA Balloon-Expandable Transcatheter Valve: Survival, Hemodynamics, and Hypoattenuated Leaflet Thickening Presenter: Kazuki Suruga October 25, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Conference News EuroPCR 2025 Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI Michael O'Riordan May 23, 2025
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Conference News EuroPCR 2024 TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis Michael O'Riordan May 16, 2024
Presentation TCT 2023 TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis Presenter: Thangam Natarajan October 24, 2023
Presentation TCT 2023 TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis Presenter: Shubhadarshini Pawar October 24, 2023
Presentation TCT 2023 TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement Presenter: Yousef Darestani October 24, 2023
Presentation TCT 2023 TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation Presenter: Daniel Overduin October 24, 2023
Presentation TVT 2023 Hypoatenuatted leaflet thickening or infective endocarditis- 1 year after TAVI complication Presenter: Joanna Nawara-Skipirzepa June 09, 2023
News Conference News PCR London Valves 2022 Registry Results See Less PVL, Pacemakers With Acurate neo2 Shelley Wood November 29, 2022
Presentation TCT 2022 TCT 363: Incidence and timing of device related thrombus in percutaneous implantable cardiac devices: A systematic review and meta-analysis Presenter: Richard Jung September 19, 2022
Presentation TCT 2022 TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis Presenter: Khawaja Akhtar September 19, 2022
Presentation TCT 2022 TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement Presenter: Mina Shafiei September 19, 2022
Presentation TCT 2022 TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves Presenter: Ali Azadani September 19, 2022
Presentation TCT 2022 TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation Presenter: Norman Mangner September 19, 2022